Skip to main content
SpringerLink
Log in

Neurodegenerative Disorders: Dementia and Parkinsonism, Lumping Together or Splitting Apart?

  • Chapter
  • First Online:
Movement Disorders in Dementias

  • 1542 Accesses

Abstract

Neurodegenerative diseases encompass several entities characterized by variable clinical features. Clinical presentation, anatomical regions affected, neuropathology, or molecular aspects of this group of diseases overlap frequently, rendering the “perfect” classification an almost impossible mission in many cases despite presence of the hallmark molecular findings. In this chapter, we will review the different classifications of neurodegenerative disorders as well as the artificial boundaries between movement disorders and dementias.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarsland D, Karlsen K. Neuropsychiatric aspects of Parkinson’s disease. Curr Psychiatry Rep. 1999;1(1):61–8.

    Article  CAS  PubMed  Google Scholar 

  • Abeliovich A, Schmitz Y, Fariñas I, et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25:239–52.

    Article  CAS  PubMed  Google Scholar 

  • Armstrong RA. The interface between Alzheimer’s disease, normal aging and related disorders. Curr Aging Sci. 2008;1:122–32.

    Article  CAS  PubMed  Google Scholar 

  • Armstrong RA, Lantos PL, Cairns NJ. Overlap between neurodegenerative disorders. Neuropathology. 2005;25:111–24.

    Article  PubMed  Google Scholar 

  • Armstrong R. On the ‘classification’ of neurodegenerative disorders: discrete entities, overlap or continuum? Folia Neuropathol. 2012;50(3):201–18.

    Article  CAS  PubMed  Google Scholar 

  • Borges JL. John Wilkins’ analytical language. In: Weinberger E et al., editors and trans. The total library: non-fiction 1922–86. London: Penguin Books; 2001. p. 229–32.

    Google Scholar 

  • Brown RG, Marsden CD. ‘Subcortical dementia’: the neuropsychological evidence. Neuroscience. 1988;25(2):363–87.

    Article  CAS  PubMed  Google Scholar 

  • Braga-Neto P, Felicio AC, Hoexter MQ, et al. Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study. Parkinsonism Relat Disord. 2012;18(7):854–8.

    Article  PubMed  Google Scholar 

  • Burn DJ, Jaros E. Multiple system atrophy: cellular and molecular pathology. Mol Pathol. 2001;54:419–26.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Carstea ED, Morris JA, Coleman KG, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277:228–31.

    Article  CAS  PubMed  Google Scholar 

  • Clark LN, Kartsaklis LA, Wolf Gilbert R, et al. Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol. 2009;66:578–83.

    PubMed Central  PubMed  Google Scholar 

  • Cummings CJ, Zoghbi HY. Trinucleotide repeats: mechanisms and pathophysiology. Annu Rev Genomics Hum Genet. 2000;1:281–328.

    Article  CAS  PubMed  Google Scholar 

  • Cummings JL. Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry. 1986;149:682–97.

    Article  CAS  PubMed  Google Scholar 

  • Darvesh S, Freedman M. Subcortical dementia: a neurobehavioral approach. Brain Cogn. 1996;31(2):230–49.

    Article  CAS  PubMed  Google Scholar 

  • Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002;61:935–46.

    CAS  PubMed  Google Scholar 

  • Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007;22(16):2314–24.

    Article  PubMed  Google Scholar 

  • Duckett S, Stern J. Origins of the Creutzfeldt and Jakob concept. J Hist Neurosci. 1999;8:21–34.

    Article  CAS  PubMed  Google Scholar 

  • Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9(9):885–94.

    Article  CAS  PubMed  Google Scholar 

  • Espay AJ, Litvan I. Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci. 2011;45(3):343–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Fahn S, Jankovic J, Hallett M. Principles and practice of movement disorders. 2nd ed. Philadelphia: Elsevier; 2011.

    Google Scholar 

  • Feany MB, Dickson DW. Neurodegenerative disorders with ex-tensive tau pathology: a comparative study and review. Ann Neurol. 1996;40:139–48.

    Article  CAS  PubMed  Google Scholar 

  • Förstl H. The Lewy body variant of Alzheimer’s disease: clinical, pathophysiological and conceptual issues. Eur Arch Psych Clin Neurol. 1999;249:64–7.

    Article  Google Scholar 

  • Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Arch Neurol. 2001;58:186–90.

    Article  CAS  PubMed  Google Scholar 

  • Galpern WR, Lang AE. Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol. 2006;59(3):449–58.

    Article  CAS  PubMed  Google Scholar 

  • Goedert M, Spillantini MG. Tau gene mutations and neurodegeneration. Biochem Soc Symp. 2001;67:59–71.

    CAS  PubMed  Google Scholar 

  • Goedert M. The significance of tau and α-synuclein inclusions in neurodegenerative disease. Curr Opin Genet Dev. 2001a;11(3):343–51.

    Article  CAS  PubMed  Google Scholar 

  • Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci. 2001b;2:492–501.

    Article  CAS  PubMed  Google Scholar 

  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368–80.

    Article  PubMed  Google Scholar 

  • Graeber MB, Kosel S, Egensperger R, Banati RB, Muller U, Bise K, Hoff P, Moller HJ, Fujisawa K, Mehraein P. Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis. Neurogenetics. 1997;1:73–80.

    Article  CAS  PubMed  Google Scholar 

  • Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009;46:73–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol. 1998;96:116–22.

    Article  CAS  PubMed  Google Scholar 

  • Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, et al. The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology. 1990;40(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  • Hardy J. Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis. 2006;9(3 Suppl):151–3.

    CAS  PubMed  Google Scholar 

  • Hasegawa M. Biochemistry and molecular biology of tauopathies. Neuropathology. 2006;26(5):484–90.

    Article  PubMed  Google Scholar 

  • Holton JL, Ghiso J, Lashley T, et al. Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol. 2001;158:515–26.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Holton JL, Lashley T, Ghiso J, et al. Familial Danish dementia: a novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol. 2002;61:254–67.

    CAS  PubMed  Google Scholar 

  • Hughes T, Ross H, Madeley P, Finlayson G, Mindham RH, Biggins CA. Subcortical dementia. BMJ. 1993;307(6902):503.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hutton M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology. 2001;56(11 Suppl 4):S21–5.

    Article  CAS  PubMed  Google Scholar 

  • Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis. 2008;5:118–21.

    Article  CAS  PubMed  Google Scholar 

  • Jellinger KA, Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol. 2008;115(4):427–36.

    Article  PubMed  Google Scholar 

  • Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G. Molecular pathophysiology and disease-modifying therapies or spinal and bulbar muscular atrophy. Arch Neurol. 2012;69(4):436–40.

    Article  PubMed  Google Scholar 

  • Kayed R, Head E, Thompson JL, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486–9.

    Article  CAS  PubMed  Google Scholar 

  • Khateeb S, Flusser H, Ofir R, Shelef I, Narkis G, Vardi G, Shorer Z, Levy R, Galil A, Elbedour K, Birk OS. PLA2G6 mutation underlies infantile neuroaxonal dystrophy. Am J Hum Genet. 2006;79(5):942–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Koeppen AH, Mazurkiewicz JE. Friedreich ataxia: neuropathology revised. J Neuropathol Exp Neurol. 2013;72(2):78–90.

    Article  CAS  PubMed  Google Scholar 

  • Koide R, Ikeuchi T, Onodera O, et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994;6:9–13.

    Article  CAS  PubMed  Google Scholar 

  • Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Arch Neurol. 2012;69(10):1326–31.

    Article  PubMed Central  PubMed  Google Scholar 

  • Kremen SA, Mendez MF, Tsai PH, Teng E. Extrapyramidal signs in the primary progressive aphasias. Am J Alzheimers Dis Other Demen. 2011;26(1):72–7.

    Article  PubMed Central  PubMed  Google Scholar 

  • Lee S, Antony L, Hartmann R, Knaus KJ, Surewicz K, Surewicz WK, Yee VC. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J. 2010;29(1):251–62.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Davoisen RC, Goetz CG, Golbe LI, Grafman J, Growden JH, Hallett M, Jankovic J, Quinn NP, Tolisa E, Zee DS, Chase TW, FitzGibbon EJ, Hall Z, Juncos J, Nelson KB, Oliver E, Pramstaller P, Reich SG, Verny M. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1–9.

    Article  CAS  PubMed  Google Scholar 

  • Ludolph AC, Kassubek J, Landwehrmeyer BG, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol. 2009;16(3):297–309.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Luheshi LM, Dobson CM. Bridging the gap: from protein misfolding to protein misfolding diseases. FEBS Lett. 2009;583:2581–6.

    Article  CAS  PubMed  Google Scholar 

  • Mackenzie IR, Rademakers R. The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics. 2007;8:237–48.

    Article  CAS  PubMed  Google Scholar 

  • Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119(1):1–4.

    Article  PubMed Central  PubMed  Google Scholar 

  • Maltête D, Guyant-Maréchal L, Mihout B, Hannequi D. Movement disorders and Creutzfeldt-Jakob disease: a review. Parkinsonism Relat Disord. 2006;12(2):65–71.

    Article  PubMed  Google Scholar 

  • Mead S, Poulter M, Uphill J. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurol. 2009;8(1):57–66.

    Article  PubMed Central  PubMed  Google Scholar 

  • Mesulam MM. A plasticity-based theory of the pathogenesis of Alzheimer’s disease. Ann N Y Acad Sci. 2000;924:42–52.

    Article  CAS  PubMed  Google Scholar 

  • Morgan NV, Westaway SK, Morton JE, et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet. 2006;38:752–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;6(314):130–3.

    Article  Google Scholar 

  • Niwa A, Matsuo K, Shindo A, Yata K, Shiraishi T, Tomimoto H. Clinical and neuropathological findings in a patient with familial Alzheimer disease showing a mutation in the PSEN1 gene. Neuropathology. 2013;33(2):199–203.

    Article  PubMed  Google Scholar 

  • Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A. Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310(6985):970–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ozawa T, Paviour D, Quinn NP. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain. 2004;127:2657–71.

    Article  PubMed  Google Scholar 

  • Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989;94:79–100.

    Article  CAS  PubMed  Google Scholar 

  • Paulsen JS. Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep. 2011;11(5):474–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pillon B, Deweer B, Agid Y, Dubois B. Explicit memory in Alzheimer’s, Huntington’s, and Parkinson’s diseases. Arch Neurol. 1993;50(4):374–9.

    Article  CAS  PubMed  Google Scholar 

  • Paisan-Ruiz C, Bhatia KP, Li A, et al. Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol. 2009;65:19–23.

    Article  PubMed  Google Scholar 

  • Patel PI, Isaya G. Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency. Am J Hum Genet. 2001;69(1):15–24.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ross CA, Tabrizi SJ. Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10(1):83–98.

    Article  CAS  PubMed  Google Scholar 

  • Rüb U, Brunt ER, Deller T. New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado-Joseph disease). Curr Opin Neurol. 2008;21(2):111–6.

    Article  PubMed  Google Scholar 

  • Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yama -nouchi H, Marayama S. Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol. 2004;63:911–8.

    PubMed  Google Scholar 

  • Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741–66.

    CAS  PubMed  Google Scholar 

  • Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med. 2009;361:1651–61.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120:545–55.

    Article  CAS  PubMed  Google Scholar 

  • Tierney M, Fisher R, Lewis A, Zorzitto M, Snow W, Reid D, Nieuwstraten P. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease. Neurology. 1988;38:359–64.

    Article  CAS  PubMed  Google Scholar 

  • Uchikado H, DelleDonne A, Ahmed Z, et al. Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol. 2006;65:387–95.

    Article  CAS  PubMed  Google Scholar 

  • Uchikado H, Tsuchiya K, Tominaga I, Togo T, Oshima K, Akiyama H, Ikeda K, Oda T, Hirayasu Y. Argyrophilic grain disease clinically mimicking Parkinson’s disease with dementia: report of an autopsy case. No To Shinkei. 2004;56(9):785–8.

    PubMed  Google Scholar 

  • Valis M, Masopust J, Bažant J, et al. Cognitive changes in spinocerebellar ataxia type 2. Neuro Endocrinol Lett. 2011;32(3):354–9.

    PubMed  Google Scholar 

  • van Slegtenhorst M, Lewis J, Hutton M. The molecular genetics of the tauopathies. Exp Gerontol. 2000;35(4):461–71.

    Article  PubMed  Google Scholar 

  • Williams DR. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J. 2006;36(10):652–60.

    Article  CAS  PubMed  Google Scholar 

  • Yamazaki M, Arai Y, Baba M, et al. Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam. J Neuropathol Exp Neurol. 2000;59:585–91.

    CAS  PubMed  Google Scholar 

  • Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG, MRC Cognitive Function, Ageing Neuropathology Study. Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology. 2008;70(13):1042–8.

    Article  CAS  PubMed  Google Scholar 

  • Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet. 2001;28(4):345–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroscience Department, Raul Carrea Institute for Neurological Research (FLENI), Universidad Catolica Argentina, Buenos Aires, Argentina

    Marcelo Merello MD, PhD

  2. Movement Disorders Section, Neuroscience Department, Raul Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina

    Malco Rossi MD

Authors
  1. Marcelo Merello MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Malco Rossi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcelo Merello MD, PhD .

Editor information

Editors and Affiliations

  1. Neuroscience Department, Universidad Catolica Argentina, Buenos Aires, Argentina

    Marcelo Merello

  2. Psychiatry and Clinical Neurosciences, University of Western Australia, Fremantle, Australia

    Sergio E. Starkstein

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Merello, M., Rossi, M. (2014). Neurodegenerative Disorders: Dementia and Parkinsonism, Lumping Together or Splitting Apart?. In: Merello, M., Starkstein, S. (eds) Movement Disorders in Dementias. Springer, London. https://doi.org/10.1007/978-1-4471-6365-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6365-7_1

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6364-0

  • Online ISBN: 978-1-4471-6365-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation